Brain ventricular volume and cerebrospinal fluid biomarkers of Alzheimer's disease
about
Sulforaphane as a potential protective phytochemical against neurodegenerative diseasesThe Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inceptionCSF T-Tau/Aβ42 predicts white matter microstructure in healthy adults at risk for Alzheimer's disease2014 Update of the Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception.MRI and histopathologic study of a novel cholesterol-fed rabbit model of xanthogranuloma.Longitudinal whole-brain atrophy and ventricular enlargement in nondemented Parkinson's disease.Reduced CSF turnover and decreased ventricular Aβ42 levels are relatedThe Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception.Jugular venous reflux and brain parenchyma volumes in elderly patients with mild cognitive impairment and Alzheimer's disease.Increased Cerebrospinal Fluid Production as a Possible Mechanism Underlying Caffeine's Protective Effect against Alzheimer's DiseaseHIV effects on age-associated neurocognitive dysfunction: premature cognitive aging or neurodegenerative disease?Temporal course of cerebrospinal fluid dynamics and amyloid accumulation in the aging rat brain from three to thirty months.Alzheimer's disease and vascular deficiency: lessons from imaging studies and down syndrome.Protective effects of isothiocyanates on blood-CSF barrier disruption induced by oxidative stress.Occupational Complexity and Cognitive Reserve in a Middle-Aged Cohort at Risk for Alzheimer's Disease.Influence of comorbidities in idiopathic normal pressure hydrocephalus - research and clinical care. A report of the ISHCSF task force on comorbidities in INPH.Imaging the Alzheimer brain.Small cisterno-lumbar gradient of phosphorylated Tau protein in geriatric patients with suspected normal pressure hydrocephalus.Cerebrospinal fluid biomarkers of Alzheimer's disease in healthy elderly.Maximizing power to track Alzheimer's disease and MCI progression by LDA-based weighting of longitudinal ventricular surface features.Serum Hepcidin Levels, Iron Dyshomeostasis and Cognitive Loss in Alzheimer's Disease.Improved Cerebrospinal Fluid-Based Discrimination between Alzheimer's Disease Patients and Controls after Correction for Ventricular Volumes.Genetic variation modifies risk for neurodegeneration based on biomarker status.Ventricular and Periventricular Anomalies in the Aging and Cognitively Impaired Brain.An automated template-based adaptive threshold approach for measuring ventricular volume enlargement in mouse brain MR microscopy.Alzheimer's Disease-Associated Cerebrospinal Fluid (CSF) Biomarkers do not Correlate with CSF Volumes or CSF Production Rate.Magnetic resonance spectroscopy reveals abnormalities of glucose metabolism in the Alzheimer's brain.Preoperative Phosphorylated Tau Concentration in the Cerebrospinal Fluid Can Predict Cognitive Function Three Years after Shunt Surgery in Patients with Idiopathic Normal Pressure HydrocephalusParticular CSF sphingolipid patterns identify iNPH and AD patients
P2860
Q21285068-1DFC2AB2-7136-4BC6-9065-FB67F3C5189CQ27006831-31F36281-EE84-4FE6-954F-1CBA3BD75C42Q28728773-FF5E8FBA-FA95-47DA-AEA0-354D241752D4Q30971403-4D305C94-6E75-4C6E-A2BA-433D150E100CQ31049589-6CE67485-5830-44E0-BF56-36270E1F02D6Q33754677-A177263E-F2D9-4C14-89AF-BDDAC6565A8BQ33898968-2A7CD281-65C6-4A9E-99CC-5B9ECEE696EAQ34065449-1C699BFC-8D1D-4E8C-8E25-2125BD1D2F44Q34493638-85100E99-5E8F-42C4-9644-93FDBDF6C917Q35030119-FF4C8A0E-41C7-4578-9050-5395BAE35953Q35276630-E9BFDC29-F94A-4096-A08E-3D386068EE25Q35742280-8F2A900B-C5A6-4662-A0AA-266498C7603BQ35778854-45A9C70F-DF92-41FC-88EC-8176276E3DCFQ36115286-8A892A65-D481-445B-B910-37155EBD6B05Q36160858-05A245F8-E0AA-4D83-BA92-2DE85A409FB8Q36945742-32DC9FF9-0DED-48FB-B92E-97A45E9B64A3Q37141502-05F8F9B6-82D9-4341-9BF0-A3E72183C766Q37223911-49A33970-1D64-47BE-B65A-46F2A7560EF5Q37524486-0C8001F5-3A69-400F-B275-F866353E8EB3Q37616894-2F0C645F-0AF9-4EAA-A5B3-32DEC8FC05E2Q37716145-02CC4E3F-ACDF-44CE-9927-BA93C563B4E2Q39036392-FBF94C9C-079C-4E5D-A0D6-C7266534532FQ46000358-05D89F5C-8514-40B2-A29B-354B76A76A21Q47833196-ED92E43A-C5E7-4252-B17E-7D8C2DC8AB47Q48301740-81A94C6D-D9B2-4CB3-AD2A-20EA1FF50BC9Q51000764-D0F67335-50AE-4489-B651-FDC95C50A682Q51761053-3120D32F-A971-496C-930B-73F111D8698AQ58730162-4CDD640A-710C-45F4-A878-1ABC5AE4C8D4Q58751934-6EEA002C-CDEB-4D6A-82F4-ADF62C171B94
P2860
Brain ventricular volume and cerebrospinal fluid biomarkers of Alzheimer's disease
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Brain ventricular volume and cerebrospinal fluid biomarkers of Alzheimer's disease
@ast
Brain ventricular volume and cerebrospinal fluid biomarkers of Alzheimer's disease
@en
Brain ventricular volume and cerebrospinal fluid biomarkers of Alzheimer's disease
@nl
type
label
Brain ventricular volume and cerebrospinal fluid biomarkers of Alzheimer's disease
@ast
Brain ventricular volume and cerebrospinal fluid biomarkers of Alzheimer's disease
@en
Brain ventricular volume and cerebrospinal fluid biomarkers of Alzheimer's disease
@nl
prefLabel
Brain ventricular volume and cerebrospinal fluid biomarkers of Alzheimer's disease
@ast
Brain ventricular volume and cerebrospinal fluid biomarkers of Alzheimer's disease
@en
Brain ventricular volume and cerebrospinal fluid biomarkers of Alzheimer's disease
@nl
P2093
P2860
P50
P921
P356
P1476
Brain ventricular volume and cerebrospinal fluid biomarkers of Alzheimer's disease
@en
P2093
Brian R Ott
Edward G Stopa
Gerald D Silverberg
John E Donahue
Ozioma C Okonkwo
Ronald A Cohen
P2860
P304
P356
10.3233/JAD-2010-1406
P577
2010-01-01T00:00:00Z